NorthWest Biotherapeutics Inc (NWBO)

[Jack2479]

As at the end of 2019 they had a balance sheet of £4.85m (made up of trade debt of £2.91m and cash in hand of £2.496m) less creditors of around £866k with just 11 staff on the books. The called up share capital paid by Toucon is listed as being one ordinary share of £1.00

Since 2019 Advent have recruited many more but as yet we don’t have any further financial information as they have opted to file the accounts not earlier than is legally required by companies house. We will see the finances of 2020 when they are filed…we are talking 20 months old financial data at this point.

That cash balance and trade debt is more than enough to fund the employment costs and additional hires. I can only assume that further project management charges to oversee the commercial build up of the site will have been invoiced… and I assume those fees are at standard project management rates which is perfectly reasonable.

I’m a long shareholder.